First Asian PA Plant Inaugurated at Shanghai

BASF has inaugurated a wholly owned 100,000 t/y plant for PA 6 and PA 6.6, sold under the "Ultramid" trademark, at Shanghai Chemical Industry Park (SCIP).

The new facility, the German group's first investment in polyamide in China, "shows our strong commitment to this market," said CEO Kurt Bock. The "innovative production setup" will allow BASF to supply its customers more quickly and with more flexibility, he added.

Albert Heuser, BASF's chief executive for Greater China, said the investment reflects management's confidence that demand for PA from the region's engineering plastics, fiber and film industries will continue to grow strongly.

Reports say caprolactam feedstock for the Chinese PA 6 plant will be supplied in part from BAFS's European production, with additional volumes to be procured locally, probably from an adjacent plant owned by US polyamide specialist Invista.

The US company is also building a PA plant at the site, earmarked for start-up later this year.

BASF is also a partner in an integrated world-scale isocyanates production at SCIP. Together with US polyurethanes specialist Huntsman, other partners in the Lianheng Isocyanate joint venture include several Chinese firms.

The joint venture recently received permission to doubling its MDI capacity to 480,000 t/y.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.